These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7476126)
1. Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Seibert SA; Howell CY; Hughes MK; Hughes AL Mol Biol Evol; 1995 Sep; 12(5):803-13. PubMed ID: 7476126 [TBL] [Abstract][Full Text] [Related]
2. Complex positive selection pressures drive the evolution of HIV-1 with different co-receptor tropisms. Zhang C; Ding N; Chen K; Yang R Sci China Life Sci; 2010 Oct; 53(10):1204-14. PubMed ID: 20953943 [TBL] [Abstract][Full Text] [Related]
3. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies. Ahmad A; Ladha A; Cohen EA; Menezes J Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893 [TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 2 (HIV-2) env gene analysis: prediction of glycoprotein epitopes important for heterotypic neutralization and evidence for three genotype clusters within the HIV-2a subtype. Breuer J; Douglas NW; Goldman N; Daniels RS J Gen Virol; 1995 Feb; 76 ( Pt 2)():333-45. PubMed ID: 7531216 [TBL] [Abstract][Full Text] [Related]
6. Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. Tebit DM; Zekeng L; Kaptué L; Salminen M; Kräusslich HG; Herchenröder O AIDS Res Hum Retroviruses; 2002 Jan; 18(1):39-48. PubMed ID: 11804555 [TBL] [Abstract][Full Text] [Related]
7. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
8. Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIVmac251): a virus stock used for international vaccine studies. Almond N; Jenkins A; Slade A; Heath A; Cranage M; Kitchin P AIDS Res Hum Retroviruses; 1992 Jan; 8(1):77-88. PubMed ID: 1736942 [TBL] [Abstract][Full Text] [Related]
9. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea. Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of 39 HIV isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. Swanson P; Devare SG; Hackett J AIDS Res Hum Retroviruses; 2003 Jul; 19(7):625-9. PubMed ID: 12921095 [TBL] [Abstract][Full Text] [Related]
11. Phylogenetic analysis of human immunodeficiency virus 1 in Ghana. Takehisa J; Osei-Kwasi M; Ayisi NK; Hishida O; Miura T; Igarashi T; Brandful J; Ampofo W; Netty VB; Mensah M; Yamashita M; Ido E; Hayami M Acta Virol; 1997 Feb; 41(1):51-4. PubMed ID: 9199716 [TBL] [Abstract][Full Text] [Related]
12. Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes. Travers SA; O'Connell MJ; McCormack GP; McInerney JO J Virol; 2005 Feb; 79(3):1836-41. PubMed ID: 15650207 [TBL] [Abstract][Full Text] [Related]
13. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Huang Y; Zhang L; Ho DD Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687 [TBL] [Abstract][Full Text] [Related]
14. Genetic characterization of HIV before widespread testing of HIV vaccine candidates at a clinical trial site in Pretoria, South Africa. Musyoki A; Mothapo K; Rakgole J; Lukhwareni A; Bessong P; Selabe G; Bredell H; Williamson C; Mphahlele MJ AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1131-8. PubMed ID: 22106990 [TBL] [Abstract][Full Text] [Related]
15. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens. Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412 [TBL] [Abstract][Full Text] [Related]
16. Positive selection and rates of evolution in immunodeficiency viruses from humans and chimpanzees. Mindell DP Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3284-8. PubMed ID: 8622929 [TBL] [Abstract][Full Text] [Related]
17. Molecular approaches to AIDS vaccine development using baculovirus expression vectors. Kang CY Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523 [No Abstract] [Full Text] [Related]
18. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1). da Silva J; Hughes AL Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432 [TBL] [Abstract][Full Text] [Related]
19. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses. Otteken A; Voss G; Hunsmann G Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426 [TBL] [Abstract][Full Text] [Related]
20. Point mutant frequencies in the pol gene of human immunodeficiency virus type 1 are two- to threefold lower than those of env. Quiñones-Mateu ME; Holguín A; Dopazo J; Nájera I; Domingo E AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1117-28. PubMed ID: 8844016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]